A Review of Implementation Strategies to Enhance PrEP Delivery for People Experiencing Housing Insecurity: Advancing a Multifaceted High-Touch, Low-Barrier Approach.

Jennifer Velloza, Nicky J Mehtani, Matthew D Hickey, Elizabeth Imbert, Ayesha Appa, Elise D Riley
Author Information
  1. Jennifer Velloza: Department of Epidemiology & Biostatistics, University of California San Francisco, 550 16th Street 2nd Floor, San Francisco, CA, 94158, USA. jennifer.velloza@ucsf.edu.
  2. Nicky J Mehtani: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  3. Matthew D Hickey: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  4. Elizabeth Imbert: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  5. Ayesha Appa: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  6. Elise D Riley: Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Abstract

PURPOSE OF REVIEW: This review summarizes key implementation strategies to advance oral and long-acting PrEP delivery for unstably housed people in the United States.
RECENT FINDINGS: People experiencing homelessness and housing instability face barriers to PrEP uptake and adherence including lack of safe medication storage, competing basic needs, insurances issues, and/or mental health or substance use disorders. Recent advancements in HIV treatment and prevention provide evidence on high-touch, low-barrier implementation approaches to address these challenges. We compiled these approaches into a multi-component implementation strategy, "SHELTER", which includes: low-barrier primary care, case management, incentives, outreach, care coordination, multidisciplinary provider collaboration, data tracking, and robust provider-patient relationships. The US has fallen short of our Ending the Epidemic targets, in part due to challenges in PrEP delivery for people experiencing housing instability. SHELTER provides a comprehensive approach for considering critical components of HIV prevention for this population that can be used in future oral and long-acting PrEP programs.

Keywords

References

  1. PLoS Med. 2016 Nov 29;13(11):e1002183 [PMID: 27898679]
  2. Am J Public Health. 2016 Jan;106(1):e1-e23 [PMID: 26562123]
  3. Contemp Clin Trials. 2023 Feb;125:107037 [PMID: 36460267]
  4. Implement Sci. 2017 Nov 14;12(1):134 [PMID: 29137666]
  5. Soc Sci Med. 2014 Jun;110:10-7 [PMID: 24704889]
  6. AIDS Care. 2023 Apr;35(4):480-487 [PMID: 35698454]
  7. Int J Audiol. 2016 Jul;55 Suppl 3:S90-8 [PMID: 27420547]
  8. J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127 [PMID: 29084044]
  9. Curr HIV/AIDS Rep. 2020 Jun;17(3):259-267 [PMID: 32382919]
  10. Implement Sci. 2011 Apr 23;6:42 [PMID: 21513547]
  11. Implement Sci. 2012 Apr 24;7:37 [PMID: 22530986]
  12. AIDS Behav. 2024 Apr;28(4):1216-1226 [PMID: 37698638]
  13. Open Forum Infect Dis. 2018 Mar 14;5(3):ofy035 [PMID: 29577059]
  14. AIDS Patient Care STDS. 2018 Apr;32(4):149-156 [PMID: 29630852]
  15. JAMA. 2001 Jan 10;285(2):200-6 [PMID: 11176814]
  16. BMC Public Health. 2023 Feb 7;23(1):263 [PMID: 36750814]
  17. Curr Opin HIV AIDS. 2019 Jan;14(1):60-65 [PMID: 30394947]
  18. Implement Sci. 2016 May 18;11(1):73 [PMID: 27193580]
  19. Implement Sci. 2013 Dec 01;8:139 [PMID: 24289295]
  20. J Acquir Immune Defic Syndr. 2024 May 1;96(1):61-67 [PMID: 38346426]
  21. Am J Public Health. 2021 Jun;111(6):1045-1048 [PMID: 33950728]
  22. J Infect Dis. 2022 Oct 7;226(Suppl 3):S353-S362 [PMID: 35759251]
  23. J Gen Intern Med. 2006 Jan;21(1):71-7 [PMID: 16423128]
  24. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):444-449 [PMID: 33136742]
  25. AIDS Care. 2020 Nov;32(11):1457-1461 [PMID: 31791132]
  26. Implement Sci. 2017 Jun 21;12(1):77 [PMID: 28637486]
  27. AIDS. 2021 Jul 1;35(8):1241-1246 [PMID: 34076613]
  28. J Adolesc Health. 2019 May;64(5):574-580 [PMID: 30254009]
  29. BMC Infect Dis. 2022 Feb 10;22(1):144 [PMID: 35144557]
  30. Int J Environ Res Public Health. 2024 Jan 25;21(2): [PMID: 38397624]
  31. J Gen Intern Med. 2023 Mar;38(4):913-921 [PMID: 35614171]
  32. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720908370 [PMID: 32100617]
  33. Adm Policy Ment Health. 2011 Mar;38(2):65-76 [PMID: 20957426]
  34. Health Promot Pract. 2024 Mar;25(2):178-182 [PMID: 36448342]
  35. Implement Sci Commun. 2024 Jan 5;5(1):4 [PMID: 38183133]
  36. AIDS Behav. 2021 May;25(5):1411-1422 [PMID: 32748159]
  37. AIDS Res Ther. 2019 Nov 9;16(1):32 [PMID: 31706357]
  38. Am J Public Health. 2012 Jul;102(7):1267-73 [PMID: 22594719]
  39. AIDS Behav. 2022 Oct;26(10):3311-3324 [PMID: 35416595]
  40. Am J Public Health. 2018 Dec;108(S7):S528-S530 [PMID: 32941772]
  41. Open Forum Infect Dis. 2019 Jun 26;6(7):ofz294 [PMID: 31341930]

Grants

  1. KL2 TR001870/NCATS NIH HHS
  2. R00 MH123369/NIMH NIH HHS
  3. KL2TR001870/NCATS NIH HHS

MeSH Term

Humans
HIV Infections
Ill-Housed Persons
Pre-Exposure Prophylaxis
Housing
Anti-HIV Agents
United States

Chemicals

Anti-HIV Agents

Word Cloud

Similar Articles

Cited By